Lorraine F. Lanyon

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

Britton Boras, Rhys Jones, Brandon J. Anson et al. · Nature Communications · 2021 · 284 citations · Full text

Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19

Britton Boras, Rhys Jones, Brandon J. Anson et al. · 2020 · 158 citations · Full text

Acoustic Ejection Mass Spectrometry for High-Throughput Analysis

Hui Zhang, Chang Liu, Wenyi Hua et al. · Analytical Chemistry · 2021 · 96 citations · Full text

Engineering, Analytical Microsystems, Spectrochemical Analysis +19

Discovery of a Highly Selective Glycogen Synthase Kinase‐3 Inhibitor (PF‐04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET Neuroimaging

Steven H. Liang, Jinshan Michael Chen, Marc D. Normandin et al. · Angewandte Chemie International Edition · 2016 · 90 citations · Full text

Spirocyclic Sulfamides as β-Secretase 1 (BACE-1) Inhibitors for the Treatment of Alzheimer’s Disease: Utilization of Structure Based Drug Design, WaterMap, and CNS Penetration Studies To Identify Centrally Efficacious Inhibitors

Michael A. Brodney, Gabriela Barreiro, Kevin Ogilvie et al. · Journal of Medicinal Chemistry · 2012 · 60 citations · Full text

Drug Target, Peptide Science, Pharmacotherapy +20